Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
chemconnection.eu

See what CB Insights has to offer

Stage

Acquired | Acquired

About ChemConnection

ChemConnection is a CDMO with a focus on the development and cGMP production of novel active pharmaceutical ingredients and nanomedicines.

ChemConnection Headquarter Location

Kloosterstraat 9

Oss, 5349,

Netherlands

+31 (0) 627035643

Latest ChemConnection News

Email to a friend Follow us on Twitter Follow us on Facebook Follow us on LinkedIn Dutch API maker bought by CDMO to boost development offering

May 14, 2018

By Flora Southey GettyImages/marchmeena29 CDMO Ardena has purchased active pharmaceutical ingredient and nanomedicine maker ChemConnection, as part of an acquisition strategy focused on development services. The merger will see Ardena onboard ChemConnection’s facility in Oss, the Netherlands, which has process and analytical development capabilities, and manufacturing and stability study technology for active pharmaceutical ingredients (APIs) and nanomedicine. Ardena did not disclose which drug ingredients are made at the site, nor how much it paid for the company. The acquisition will increase Ardena’s headcount from 140 to 200 employees. Ardena CEO Harry Christiaens told us its acquisition strategy focuses on API development, rather than commercial API manufacturing. “Our strategy is to be a development company providing integrated services throughout the clinical supply chain: API, drug product, pack and label, patient kits and bioanalysis.”​ Until this acquisition, the firm was primarily focused on pharmaceutical development manufacturing of drug products, said Christiaens. “With the acquisition of ChemConnection, we strengthen our offering with complementary drug substances services.​ “Moreover, the team in Oss is globally reputed for its nanomedicine expertise enabling the targeted delivery of complex small molecules and biomolecules.”​ Belgium-headquartered Ardena – the result of a merger between Pharmavize, Crystallics and Analytical Biochemical Laboratory (ABL) – launched ​ in September last year. The contract development and manufacturing organisation (CDMO) offers solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing services. Copyright - Unless otherwise stated all contents of this web site are © 2020 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ChemConnection

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ChemConnection is included in 1 Expert Collection, including Nanobiotechnology.

N

Nanobiotechnology

701 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.